ARNA
Last Trade: 13.70 Dec 13
After Hours Change: 2.29 (20.07%)
Today's Change: 2.28 (19.96%)
Bid: 13.63
Ask: 13.80
وهذا الخبر
Shares of Arena Pharmaceuticals Inc. surged in late trading Tuesday after the drug maker reported positive results from a midstage clinical trial of its obesity treatment.
After 12 weeks of using the drug, patients in the double-blinded, dose-ranging study showed a statistically significant amount of weight loss, Arena said.
Patients dropped an average of 4 pounds, 5.7 pounds and 7.9 pounds at respective daily doses of 10 milligrams, 15 milligrams and 20 milligrams.
The company added that the drug, APD356, was well tolerated at all doses and had no apparent effects on heart valves or pulmonary artery pressure.
Arena shares fell a penny to $11.41 on the Nasdaq before climbing $2.04, or 17.9 percent in after-hours activity.
الشركه فى طريقها لطرح عقار ناجح لتخفيف الوزن واحتمال منتصف 2006
يبيلها متابعه اليوم ( انه حقا سهم محترم )